Mark Hubbard

641 total citations
15 papers, 397 citations indexed

About

Mark Hubbard is a scholar working on Molecular Biology, Ecology and Epidemiology. According to data from OpenAlex, Mark Hubbard has authored 15 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Ecology and 4 papers in Epidemiology. Recurrent topics in Mark Hubbard's work include Bacteriophages and microbial interactions (4 papers), Bacillus and Francisella bacterial research (3 papers) and Horticultural and Viticultural Research (3 papers). Mark Hubbard is often cited by papers focused on Bacteriophages and microbial interactions (4 papers), Bacillus and Francisella bacterial research (3 papers) and Horticultural and Viticultural Research (3 papers). Mark Hubbard collaborates with scholars based in United States, Australia and Italy. Mark Hubbard's co-authors include Paul R. Gross, Leonard I. Malkin, Robert Ballard, Albert G. Abbott, David P. AuCoin, Jeffrey D. Kelly, Paul J. Brett, S. Rajapakse, Michael J. Dillon and Mary N. Burtnick and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

Mark Hubbard

14 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Hubbard United States	10	157	114	61	52	39	15	397
Romain Froquet Switzerland	11	189 1.2×	30 0.3×	59 1.0×	20 0.4×	39 1.0×	13	428
Karl Poetter United States	10	372 2.4×	49 0.4×	84 1.4×	28 0.5×	61 1.6×	12	735
Marlon Dias Mariano Santos Brazil	10	253 1.6×	81 0.7×	24 0.4×	20 0.4×	35 0.9×	40	435
M. Ehn Sweden	8	261 1.7×	40 0.4×	24 0.4×	27 0.5×	39 1.0×	9	375
Xuyang Zheng China	13	237 1.5×	59 0.5×	54 0.9×	20 0.4×	20 0.5×	35	635
Priscila Ferreira de Aquino Brazil	9	206 1.3×	64 0.6×	27 0.4×	14 0.3×	38 1.0×	27	396
Estefanía Rodríguez Germany	14	341 2.2×	89 0.8×	76 1.2×	34 0.7×	74 1.9×	27	638
O. S. Morenkov Russia	12	160 1.0×	93 0.8×	16 0.3×	26 0.5×	50 1.3×	33	333
M. Herrera United States	5	86 0.5×	64 0.6×	73 1.2×	12 0.2×	43 1.1×	7	333
Claire Walker United Kingdom	10	154 1.0×	70 0.6×	183 3.0×	9 0.2×	18 0.5×	14	525

Countries citing papers authored by Mark Hubbard

Since Specialization

Citations

This map shows the geographic impact of Mark Hubbard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Hubbard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Hubbard more than expected).

Fields of papers citing papers by Mark Hubbard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Hubbard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Hubbard. The network helps show where Mark Hubbard may publish in the future.

Co-authorship network of co-authors of Mark Hubbard

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Hubbard. A scholar is included among the top collaborators of Mark Hubbard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Hubbard. Mark Hubbard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Hubbard, Mark, et al.. (2024). Evaluation of Alinity m CMV assay performance for detecting CMV in plasma, cerebrospinal fluid, and bronchoalveolar lavage specimens. Diagnostic Microbiology and Infectious Disease. 109(3). 116301–116301.

Lee, Angela C., et al.. (2022). Postanesthesia complications in pediatric patients with previous SARS‐CoV‐2 infection: A cohort study. Pediatric Anesthesia. 33(1). 79–85. 5 indexed citations

Gates‐Hollingsworth, Marcellene A., J. R. Needham, Raymond L. Houghton, et al.. (2015). Immunoassay for Capsular Antigen of Bacillus anthracis Enables Rapid Diagnosis in a Rabbit Model of Inhalational Anthrax. PLoS ONE. 10(5). e0126304–e0126304. 12 indexed citations

Marchetti, Roberta, Michael J. Dillon, Mary N. Burtnick, et al.. (2015). Burkholderia pseudomallei Capsular Polysaccharide Recognition by a Monoclonal Antibody Reveals Key Details toward a Biodefense Vaccine and Diagnostics against Melioidosis. ACS Chemical Biology. 10(10). 2295–2302. 34 indexed citations

Houghton, Raymond L., Mark Hubbard, Michael J. Dillon, et al.. (2014). Development of a Prototype Lateral Flow Immunoassay (LFI) for the Rapid Diagnosis of Melioidosis. PLoS neglected tropical diseases. 8(3). e2727–e2727. 107 indexed citations

Hubbard, Mark, David P. AuCoin, Peter Thorkildson, et al.. (2013). IgG Subclass and Heavy Chain Domains Contribute to Binding and Protection by mAbs to the Poly γ-D-glutamic Acid Capsular Antigen of Bacillus anthracis. PLoS Pathogens. 9(4). e1003306–e1003306. 25 indexed citations

Hubbard, Mark, Peter Thorkildson, William H. Welch, & Thomas R. Kozel. (2013). Stereo-selective binding of monoclonal antibodies to the poly-gamma-d-glutamic acid capsular antigen of Bacillus anthracis. Molecular Immunology. 55(3-4). 337–344. 3 indexed citations

Hubbard, Mark, Peter Thorkildson, Thomas R. Kozel, & David P. AuCoin. (2013). Constant domains influence binding of mouse–human chimeric antibodies to the capsular polypeptide ofBacillus anthracis. Virulence. 4(6). 483–488. 11 indexed citations

Hubbard, Mark, Jeffrey D. Kelly, S. Rajapakse, Albert G. Abbott, & Robert Ballard. (1992). Restriction Fragment Length Polymorphisms in Rose and Their Use for Cultivar Identification. HortScience. 27(2). 172–173. 45 indexed citations

10.

Hubbard, Mark, et al.. (1992). Identification of rose cultivars by restriction fragment length polymorphism. Scientia Horticulturae. 52(3). 237–245. 29 indexed citations

11.

Hubbard, Mark, et al.. (1991). IDENTIFICATION OF ROSE CULTIVARS BY RESTRICTION FRAGMENT LENGTH POLYMORPHISMS. HortScience. 26(5). 484b–484. 2 indexed citations

12.

Hubbard, Mark, et al.. (1975). Hemoglobin atlanta or α2β275 Leu→Pro (E19); An unstable variant found in several members of a caucasian family. Biochimica et Biophysica Acta (BBA) - Protein Structure. 386(2). 538–541. 18 indexed citations

13.

Fairley, K. F., Mark Hubbard, & J. A. Whitworth. (1974). PROPHYLACTIC LONG‐TERM CEPHALEXIN IN RECURRENT URINARY INFECTION. The Medical Journal of Australia. 1(9). 318–319. 9 indexed citations

14.

Huisman, T. H. J., J. B. Wilson, M. E. Gravely, & Mark Hubbard. (1974). Hemoglobin Grady: The First Example of a Variant with Elongated Chains Due to an Insertion of Residues. Proceedings of the National Academy of Sciences. 71(8). 3270–3273. 26 indexed citations

15.

Gross, Paul R., Leonard I. Malkin, & Mark Hubbard. (1965). Synthesis of RNA during oogenesis in the sea urchin. Journal of Molecular Biology. 13(2). 463–IN17. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact